Author:
Forti R L,Moldovan R A,Mitchell W M,Callicoat P,Schuffman S S,Davies H A,Smith D M
Abstract
A rapid, quantitative, and nonsubjective method of interferon assay is described, which can be readily applied to clinical specimens. Automated data acquisition and data reduction allowed a significant increase in volume per unit of time over existing methodologies. Plasma always yielded higher (usually 2:1) interferon values than did serum obtained simultaneously. Ranges of interferon levels in plasma in normal control populations are reported as well as ranges for clinical virology laboratory technicians and patients with terminal malignancies or collagen vascular diseases.
Publisher
American Society for Microbiology
Reference6 articles.
1. Production, purification, and clinical application of human fibroblast interferon;Carter W. A.;Pharmacol. Ther.,1979
2. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays;Finter N. B.;J. Gen. Virol.,1969
3. Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect;McManus N. H.;Appl. Environ. Microbiol.,1976
4. Mitchell W. M. and R. L. Forti. 1984. Progress in the monitoring of human interferon in body fluids and the phenotypic expression of human interferon activity p. 101-119. In M. Stefanini (ed.) Progress in clinical pathology vol. 9. Grune and Stratton New York.
5. Systemic Iupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon;Preble 0.;Science,1982
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献